Avistone Pharmaceuticals
PrivateLast Round
Series B
Jan 4, 2024
Total Funding Raised
$340M
Company Overview
Avistone Pharmaceuticals is a biotechnology company that develops innovative drugs for tumor treatment and precision oncology therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avistone Pharmaceuticals Comparables
Compare Avistone Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HaiHe Biopharma | 86% | |
| Apollomics | 84% | |
| HUTCHMED (China) Limited | 83% | |
Avistone Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2024 | ||||
| Series A | Dec 8, 2021 |
Avistone Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series B |
| IDG Capital | Series B |
| Yanchuang Capital | Series B |
| SDIC Unity Capital | Series B |
| IDG Capital | Series B |
| Bain Capital, LP | Series A, Series B |
| Primavera Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Presented results at the ASCO Annual Meeting 2025.
- Jun 1, 2025
Encouraging results for combination therapy in lung cancer presented at ASCO.
Avistone Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avistone Pharmaceuticals's valuation, stock price, and market status.